-
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo
de Jong, G., Bartels, L., Kedde, M., Verdegaal, E. M. E., Gillissen, M. A., Levie, S. E., Cercel, M. G., van Hal-van Veen, S. E., Fatmawati, C., van de Berg, D., Yasuda, E., Claassen, Y. B., Bakker, A. Q., van der Burg, S. H., Schotte, R., Villaudy, J., Spits, H., Hazenberg, M. D., van Helden, P. M. & Wagner, K., Jun 2021, In: Cancer Immunology, Immunotherapy. 70, 6, p. 1569-1581 13 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Tumour-reactive B cells and antibody responses after allogeneic haematopoietic cell transplantation
de Jong, G., Gillissen, M. A., Spits, H. & Hazenberg, M. D., 1 Sept 2020, In: Immuno-Oncology and Technology. 7, p. 15-22Research output: Contribution to journal › Review article › Academic › peer-review
-
A chemo-enzymatically linked bispecific antibody retargets T cells to a sialylated epitope on CD43 in acute myeloid leukemia
Bartels, L., De Jong, G., Gillissen, M. A., Yasuda, E., Kattler, V., Bru, C., Fatmawati, C., Van Hal-Van Veen, S. E., Cercel, M. G., Moiset, G., Bakker, A. Q., Van Helden, P. M., Villaudy, J., Hazenberg, M. D., Spits, H. & Wagner, K., 1 Jul 2019, In: Cancer research. 79, 13, p. 3372-3382 11 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
